Clinical Significance of Kallikrein As A Diagnostic and Prognostic Biomarker in Cardiorenal Syndrome Associated with Chronic Heart Failure
International Journal of Medical Science and Public Health Research · 01.04.2026 · 7 (4) · 10-13
DOI: 10.37547/ijmsphr/volume07issue04-02 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Medical Science and Public Health Research, online erschienen am 01.04.2026. Verfasst von Abdigaffar Gadaev und 2 weiteren Autor:innen.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Background
Chronic heart failure (CHF) remains one of the leading challenges in modern healthcare systems worldwide and is frequently accompanied by impaired renal function. The progressive and interrelated deterioration of cardiac and renal function leads to the development of cardiorenal syndrome (CRS), which significantly worsens patient prognosis. In recent years, alongside neurohumoral mechanisms, the kallikrein–kinin system has been increasingly recognized as an important contributor to CRS pathogenesis; however, its diagnostic value has not yet been sufficiently elucidated.
Objective
To evaluate the diagnostic and potential prognostic significance of kallikrein levels in the early stages of cardiorenal syndrome developing in patients with chronic heart failure, and to determine their relationship with NT-proBNP, aldosterone, and renal function parameters.
Methods
This prospective observational study included 115 patients with chronic heart failure classified as New York Heart Association (NYHA) functional classes II–III. Patients were divided into two groups according to functional class. Serum levels of kallikrein, NT-proBNP, aldosterone, cystatin C, and creatinine were measured. Glomerular filtration rate (GFR) was calculated using the CKD-EPI equation. Statistical analysis was performed using Student’s t-test and Pearson correlation analysis.
Results
Kallikrein levels were significantly lower in patients with NYHA class III compared to class II (535.86±12.37 vs. 778.79±17.8 ng/mL; p
Zitieren
APA
Gadaev, A., Rakhimova, M., & Muzaffarov, J. (2026). Clinical Significance of Kallikrein As A Diagnostic and Prognostic Biomarker in Cardiorenal Syndrome Associated with Chronic Heart Failure. International Journal of Medical Science and Public Health Research, 7(4), 10-13. https://doi.org/10.37547/ijmsphr/volume07issue04-02
Vancouver
Gadaev A, Rakhimova M, Muzaffarov J. Clinical Significance of Kallikrein As A Diagnostic and Prognostic Biomarker in Cardiorenal Syndrome Associated with Chronic Heart Failure. International Journal of Medical Science and Public Health Research. 2026;7(4):10-13. doi:10.37547/ijmsphr/volume07issue04-02
BibTeX
@article{Gadaev2026,
author = {Gadaev, Abdigaffar and Rakhimova, Matluba and Muzaffarov, Jahongir},
title = {Clinical Significance of Kallikrein As A Diagnostic and Prognostic Biomarker in Cardiorenal Syndrome Associated with Chronic Heart Failure},
journal = {International Journal of Medical Science and Public Health Research},
year = {2026},
volume = {7},
number = {4},
pages = {10--13},
doi = {10.37547/ijmsphr/volume07issue04-02}
}
EUVIMED